Wolverine Trading
ICPT

Wolverine Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wolverine Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,482
Closed -$146K – 5177
2023
Q1 		$141K Buy
+10,482
New +$181K ﹤0.01% 3563
2020
Q4 		– Sell
-7,765
Closed -$257K – 5639
2020
Q3 		$324K Sell
7,765
-3,561
-31% -$164K ﹤0.01% 3302
2020
Q2 		$529K Sell
11,326
-10,336
-48% -$798K ﹤0.01% 2675
2020
Q1 		$1.41M Buy
21,662
+4,346
+25% +$391K ﹤0.01% 1638
2019
Q4 		$2.14M Sell
17,316
-31,328
-64% -$2.8M 0.01% 1785
2019
Q3 		$3.12M Sell
48,644
-10,114
-17% -$679K 0.01% 1136
2019
Q2 		$4.67M Buy
58,758
+16,454
+39% +$1.47M 0.01% 924
2019
Q1 		$4.73M Buy
42,304
+6,899
+19% +$754K 0.01% 910
2018
Q4 		$3.33M Buy
35,405
+11,365
+47% +$1.18M 0.01% 1064
2018
Q3 		$3.04M Sell
24,040
-22,522
-48% -$2.38M 0.01% 1328
2018
Q2 		$2.86M Hold
46,562
– – 0.01% 1281
2018
Q1 		$2.86M Buy
+46,562
New +$2.81M 0.01% 1281
2017
Q3 		– Sell
-17,335
Closed -$2.13M – 5222
2017
Q2 		$2.13M Sell
17,335
-1,950
-10% -$226K 0.01% 1201
2017
Q1 		$2.18M Buy
+19,285
New +$2.25M 0.01% 1132

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Wolverine Trading's ICPT Position: Q2 2023 in Review

Wolverine Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 10,482 shares — an estimated $146K sold.

Wolverine Trading first reported a position in ICPT in Q1 2017 and held it in 14 quarters. The position peaked at $4.73M in Q1 2019. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Wolverine Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 10,482 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $146K.
  • Wolverine Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 14 quarters.
  • Wolverine Trading's Intercept Pharmaceuticals, Inc. position peaked at $4.73M in Q1 2019.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.